These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25446730)

  • 1. IBD: cathelicidin can reverse intestinal fibrosis in models of colitis.
    Leake I
    Nat Rev Gastroenterol Hepatol; 2015 Jan; 12(1):3. PubMed ID: 25446730
    [No Abstract]   [Full Text] [Related]  

  • 2. Cathelicidin-BF, a Novel Antimicrobial Peptide from Bungarus fasciatus, Attenuates Disease in a Dextran Sulfate Sodium Model of Colitis.
    Zhang H; Xia X; Han F; Jiang Q; Rong Y; Song D; Wang Y
    Mol Pharm; 2015 May; 12(5):1648-61. PubMed ID: 25807257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.
    Schauber J; Rieger D; Weiler F; Wehkamp J; Eck M; Fellermann K; Scheppach W; Gallo RL; Stange EF
    Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):615-21. PubMed ID: 16702850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.
    Tran DH; Wang J; Ha C; Ho W; Mattai SA; Oikonomopoulos A; Weiss G; Lacey P; Cheng M; Shieh C; Mussatto CC; Ho S; Hommes D; Koon HW
    BMC Gastroenterol; 2017 May; 17(1):63. PubMed ID: 28494754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.
    Cobo ER; Kissoon-Singh V; Moreau F; Holani R; Chadee K
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.
    Sun L; Wang W; Xiao W; Yang H
    Inflamm Bowel Dis; 2016 Aug; 22(8):1986-91. PubMed ID: 27135484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathelicidins and functional analogues as antisepsis molecules.
    Mookherjee N; Rehaume LM; Hancock RE
    Expert Opin Ther Targets; 2007 Aug; 11(8):993-1004. PubMed ID: 17665972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases.
    Fabisiak N; Fabisiak A; Chmielowiec-Korzeniowska A; Tymczyna L; Kamysz W; Kordek R; Bauer M; Kamysz E; Fichna J
    Pharmacol Rep; 2021 Feb; 73(1):163-171. PubMed ID: 33219923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letting the CAThelicidin out of the bag, as a therapeutic modulator of the adaptive immune system.
    Davidson DJ; Currie AJ
    Leuk Res; 2005 May; 29(5):477-9. PubMed ID: 15755499
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic murine cathelicidin CRAMP safely attenuated colonic neutrophil infiltration in pigs.
    Fodor CC; McCorkell R; Muench G; Cobo ER
    Vet Immunol Immunopathol; 2022 Jul; 249():110443. PubMed ID: 35640361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production.
    Holani R; Babbar A; Blyth GAD; Lopes F; Jijon H; McKay DM; Hollenberg MD; Cobo ER
    Gut Microbes; 2020 Nov; 12(1):1785802. PubMed ID: 32658599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.
    Wu WK; Wang G; Coffelt SB; Betancourt AM; Lee CW; Fan D; Wu K; Yu J; Sung JJ; Cho CH
    Int J Cancer; 2010 Oct; 127(8):1741-7. PubMed ID: 20521250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathelicidin signaling via the Toll-like receptor protects against colitis in mice.
    Koon HW; Shih DQ; Chen J; Bakirtzi K; Hing TC; Law I; Ho S; Ichikawa R; Zhao D; Xu H; Gallo R; Dempsey P; Cheng G; Targan SR; Pothoulakis C
    Gastroenterology; 2011 Nov; 141(5):1852-63.e1-3. PubMed ID: 21762664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c mice.
    Li Y; Chu X; Liu C; Huang W; Yao Y; Xia Y; Sun P; Long Q; Feng X; Li K; Yang X; Bai H; Sun W; Ma Y
    Hum Vaccin Immunother; 2018 Jan; 14(1):146-158. PubMed ID: 29049008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antimicrobial peptide modulates epithelial responses to bacterial products.
    Vonk MJ; Hiemstra PS; Grote JJ
    Laryngoscope; 2008 May; 118(5):816-20. PubMed ID: 18300705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells.
    Gubatan J; Mehigan GA; Villegas F; Mitsuhashi S; Longhi MS; Malvar G; Csizmadia E; Robson S; Moss AC
    Inflamm Bowel Dis; 2020 May; 26(6):885-897. PubMed ID: 31955203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cathelicidin LL-37-derived peptide IG-19 confers protection in a murine model of collagen-induced arthritis.
    Chow LN; Choi KY; Piyadasa H; Bossert M; Uzonna J; Klonisch T; Mookherjee N
    Mol Immunol; 2014 Feb; 57(2):86-92. PubMed ID: 24091294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
    Fahy RJ; Wewers MD
    Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antimicrobial peptide cathelicidin-BF could be a potential therapeutic for Salmonella typhimurium infection.
    Xia X; Zhang L; Wang Y
    Microbiol Res; 2015 Feb; 171():45-51. PubMed ID: 25644952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study of antimicrobial peptide cathelicidin-PY therapy in mice with acute liver failure].
    Wang Y; Huang XP; Gan JH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):254-258. PubMed ID: 32306659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.